» Articles » PMID: 37642987

A Distinct Nasal Microbiota Signature in Peritoneal Dialysis Patients

References
1.
Hasegawa K, Linnemann R, Mansbach J, Ajami N, Espinola J, Petrosino J . Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study. Pediatr Infect Dis J. 2016; 36(11):1044-1051. PMC: 5479744. DOI: 10.1097/INF.0000000000001500. View

2.
Straub D, Blackwell N, Langarica-Fuentes A, Peltzer A, Nahnsen S, Kleindienst S . Interpretations of Environmental Microbial Community Studies Are Biased by the Selected 16S rRNA (Gene) Amplicon Sequencing Pipeline. Front Microbiol. 2020; 11:550420. PMC: 7645116. DOI: 10.3389/fmicb.2020.550420. View

3.
. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol. 1996; 7(11):2403-8. DOI: 10.1681/ASN.V7112403. View

4.
Ewels P, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A . The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020; 38(3):276-278. DOI: 10.1038/s41587-020-0439-x. View

5.
Luzar M, Coles G, Faller B, Slingeneyer A, Dah G, Briat C . Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med. 1990; 322(8):505-9. DOI: 10.1056/NEJM199002223220804. View